Analysis Of Income And Expense [Abstract]

BioArctic - Filing #5863027

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
257 352 SEK
615 995 SEK
Material income and expense [abstract]
Research and development expense
311 145 SEK
172 135 SEK
Other operating income (expense)
3 740 SEK
4 082 SEK
Miscellaneous other operating expense
2 638 SEK
8 132 SEK
Operating expense
458 883 SEK
348 368 SEK
Sales and marketing expense
55 461 SEK
43 706 SEK
Miscellaneous other comprehensive income [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations
42,000 SEK
26,000 SEK
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
177 037 SEK
177 037 SEK
229 220 SEK
229 220 SEK
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
177 038 SEK
229 223 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.